logo
Select company
Select metric
$ -255KNet Cash Flow - Financing
VS
Market
49
Sector
74
Industry
88
History
93
$ 0.37Close
$ 0.29 - $ 4.28 52-Week Range
Ticker Information

Ticker

VYNE

Company Name

VYNE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VYNE THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VYNE - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ -255K
3/31/2025$ -224K
12/31/2024$ -141K
9/30/2024$ 82.65M
6/30/2024$ 82.61M
3/31/2024$ 82.61M
12/31/2023$ 82.39M
9/30/2023$ -61K
6/30/2023$ -40K
3/31/2023$ -96K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VYNE THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 53.7M.
  • Over the past 5 years, VYNE THERAPEUTICS INC's average CF - Financing has been $ 34.39M.
  • The median CF - Financing for VYNE THERAPEUTICS INC during this period was $ 20.71M
  • VYNE THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 135.17M.
  • The lowest CF - Financing recorded by VYNE THERAPEUTICS INC in the same timeframe $ -32.19M

VYNE THERAPEUTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
ERNA : ERNEXA THERAPEUTICS INC $ 12.08MBRTX : BIORESTORATIVE THERAPIES INC $ 1.85MHCWB : HCW BIOLOGICS INC $ 13.99MLYRA : LYRA THERAPEUTICS INC $ 4.62MAPRE : APREA THERAPEUTICS INC $ 573.98KAIM : AIM IMMUNOTECH INC $ 2.19MIBIO : IBIO INC $ 8.93MADIL : ADIAL PHARMACEUTICALS INC $ 8.96MCELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ 4.96MDWTX : DOGWOOD THERAPEUTICS INC $ 22.5M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

VYNE - Net Cash Flow - Financing, Last 5 years

$ -32.19M

Minimum

Mar 31, 2022

$ 135.17M

Maximum

Mar 31, 2021

$ 34.39M

Average

$ 20.71M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M